STRATA Skin Sciences, Inc. (SSKN)

NASDAQ: SSKN · IEX Real-Time Price · USD
-0.070 (-7.62%)
Mar 17, 2023, 4:00 PM EDT - Market closed

Company Description

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.

Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions.

The company distributes its products internationally through distributors, and domestically directly to physicians.

The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.

STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

STRATA Skin Sciences, Inc.
STRATA Skin Sciences logo
Country United States
Founded 1989
IPO Date Oct 28, 2005
Industry Medical Devices
Sector Healthcare
Employees 115
CEO Dolev Rafaeli

Contact Details

5 Walnut Grove Drive, Suite 140
Horsham, Pennsylvania 19044
United States
Phone 215-619-3200

Stock Details

Ticker Symbol SSKN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001051514
CUSIP Number 86272A206
ISIN Number US86272A2069
Employer ID 13-3986004
SIC Code 3841

Key Executives

Name Position
William D. Humphries M.B.A. Executive Chairman
Robert J. Moccia President, Chief Executive Officer and Director
Christopher Lesovitz Chief Financial Officer
Jay Sturm General Counsel and Corporate Secretary
Keith Simeone Vice President of Sales
Dr. Darrell S. Rigel Chief Medical Advisor
Shmuel Gov Executive Vice President and GM
Michael E. Goodman Head of International Sales
Nikolai Kabelev Vice President of Research & Development
Michael R. Stewart Independent Consultant

Latest SEC Filings

Date Type Title
Mar 13, 2023 8-K Current Report
Feb 27, 2023 8-K Current Report
Feb 14, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 1, 2023 8-K Current Report
Jan 9, 2023 8-K Current Report
Jan 9, 2023 8-K Current Report
Nov 9, 2022 10-Q Quarterly Report
Nov 9, 2022 8-K Current Report
Oct 28, 2022 8-K Current Report